A Case Report of Successful Treatment of Metastatic Gastral Neuroendocrine Carcinoma to a Small-Molecule VEGFR-2 Tyrosine Kinase Inhibitor Apatinib

Biomedical Research
doi 10.4066/biomedicalresearch.29-17-3677
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Metastatic Adamantinoma Responds to Treatment With Receptor Tyrosine Kinase Inhibitor

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2010English

Phase 2 Study of Apatinib, a Novel VEGFR Inhibitor in Patients With Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Head and Neck: Preliminary Results

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2018English

A Unique Bleeding-Related Complication of Sorafenib, a Tyrosine Kinase Inhibitor, in Advanced Hepatocellular Carcinoma: A Case Report

Journal of Medical Case Reports
Medicine
2014English

Evaluation of RET Tyrosine Kinase as a Novel Driver of Prostatic Small Cell Neuroendocrine Carcinoma

2015English

Successful Treatment of Metastatic Upper Tract Urothelial Carcinoma With Vemurafenib: Case Report

Clinical Genitourinary Cancer
OncologyUrology
2017English

Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, Against VEGFR-1 and Members of the Structurally Related PDGFR Family

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

Successful Treatment Using Apatinib in Intractable Brain Edema: A Case Report and Literatures Review

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

Small Molecule FLT3 Tyrosine Kinase Inhibitors

2012English

Acute Renal Failure Due to Small Cell Neuroendocrine Carcinoma of the Left Kidney: A Case Report

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy